NextGenPCR® | From hours to minutes | High throughput | Any assay

SARS-CoV-2 detection and sequencing

nextGenPCR® detecting SARS-CoV-2

SARS-CoV-2 (variant) detection solutions with the NextGenPCR®

NextGenPCR® has developed two unique solutions for SARS-CoV-2 detection and variant surveillance. Our fluorescence probe based screening solution enables you to determine an active SARS-CoV-2 infection directly from a clinical sample within 27 minutes. With the NextGenPCR® variant nanopore sequencing solution you can achieve ultrafast viral genotyping and increase the speed of your nanopore workflow up to 4 times. Find more information below.

SARS-CoV-2 FLUORESCENCE PROBE BASED SCREENING

  • Validated direct RT-PCR detection of SARS-CoV-2
  • Cycling program in just 27 minutes
  • Sensitivity of 1 copy per microliter sample
  • Excellent concordance to referenced qPCR methods
  • Multi-target design insures detection of all viral variants

SARS-cov-2 fluorescence probe based screening

Step 1: Heat Treatment

FIRST STEP

Step 2: Pipetting & Sealing

SECOND STEP

Step 3: NextGenPCR® - 27 minutes

THIRD STEP

Step 4: Plate read out

FOURTH STEP

SARS-CoV-2
VARIANT NANOPORE SEQUENCING

Step 1: Pipetting & Sealing

FIRST STEP

Step 2: NextGenPCR®

SECOND STEP

Step 3: Sample Retrieval

THIRD STEP

Step 4: Loading Oxford Nanopore

FOURTH STEP

How to use NextGenPCR® to control the SARS-CoV-2 pandemic?

There are many examples where speed of detection of SARS-CoV-2 is beneficial or even indispensable. Before boarding an airplane all passengers can have a PCR-test performed just before take-off. This is the best way of preventing multiple infections during travel. Patients and employees entering a hospital can be tested before entering. They can then be refused entry or kept separate immediately. This will prevent infections of already vulnerable people. Many other examples exist.

A PCR-test from sample to result in less than 30 minutes will be a big help in all of these examples.

On top of that an important part of controlling a pandemic is understanding how the SARS-CoV-2 virus evolves in in a population and which mutations make it more contagious and/or are more disease causing or even lethal. By using NextGenPCR® the number of nanopore sequencing runs that can be performed goes from 1 per day to 4 per day. Gathering 4 times more data about the variants that infect a population means a much better understanding of the spread of the disease and therefore, a much better chance to control the SARS-CoV-2 pandemic.

At MBS (Molecular Biology Systems) we continuously strive to develop and improve SARS-CoV-2 PCR products available in our portfolio. Our products provide laboratories with the necessary tools to help combat the ongoing Covid-19 pandemic. MBS is proud to be part of an effective fight against this Corona Virus. Join us in this fight by filling out the form below and contact us.

Peer-reviewed publication detailing assay performance
Or download the PDF

Let’s get started on SARS-CoV-2 detection and sequencing as soon as possible:

To inquire about NextGenPCR® solutions, please contact us via the contact form below.

Success Stories